Delayed Gelatinase Inhibition Induces Reticulon 4 Receptor Expression in the Peri-Infarct Cortex

J Neuropathol Exp Neurol. 2016 Apr;75(4):379-85. doi: 10.1093/jnen/nlw011. Epub 2016 Mar 4.

Abstract

Matrix metalloproteinase (MMP) inhibition can potentially prevent hemorrhagic transformation following cerebral infarction; however, delayed-phase MMP activity is also necessary for functional recovery after experimental stroke. We sought to identify potential mechanisms responsible for the impaired recovery associated with subacute MMP inhibition in a transient middle cerebral artery occlusion model of focal ischemia in CD rats. Gelatinase inhibition was achieved by intracerebral injection of the Fn-439 MMP inhibitor 7 days after stroke. Treatment efficacy was determined on day 9 by in situ gelatin zymography. The peri-infarct cortex was identified by triphenyl tetrazolium chloride staining, and tissue samples were dissected for TaqMan array gene-expression study. Of 84 genes known to influence poststroke regeneration, we found upregulation of mRNA for the reticulon 4 receptor (Rtn4r), a major inhibitor of regenerative nerve growth in the adult CNS, and borderline expression changes for 3 additional genes (DCC, Jun, and Ngfr). Western blot confirmed increased Rtn4r protein in the peri-infarct cortex of treated animals, and double immunolabeling showed colocalization primarily with the S100 astrocyte marker. These data suggest that increased Rtn4 receptor expression in the perilesional cortex may contribute to the impaired regeneration associated with MMP inhibition in the subacute phase of cerebral infarction.

Keywords: Gelatinase; Middle cerebral artery occlusion; Nogo; Reactive astrocytes; Reticulon4 receptor..

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Infarction / metabolism*
  • Brain Infarction / pathology*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • GPI-Linked Proteins / genetics
  • GPI-Linked Proteins / metabolism
  • Gelatinases / metabolism*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Hydroxamic Acids / pharmacology
  • Infarction, Middle Cerebral Artery / complications
  • Laser-Doppler Flowmetry
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism
  • Myelin Proteins / genetics
  • Myelin Proteins / metabolism*
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Nogo Receptor 1
  • Oligopeptides / pharmacology
  • RNA, Messenger / metabolism
  • Rats
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism*

Substances

  • 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid
  • Enzyme Inhibitors
  • GPI-Linked Proteins
  • Hydroxamic Acids
  • Myelin Proteins
  • Nerve Tissue Proteins
  • Nogo Receptor 1
  • Oligopeptides
  • RNA, Messenger
  • Receptors, Cell Surface
  • Rtn4r protein, rat
  • Gelatinases
  • Matrix Metalloproteinases